Grupo Espanol De Tumores Neuroendocrinos

This study is testing the drug cabozantinib for people with advanced thyroid cancer that has stopped responding to radioactive iodine and other targeted drugs. The main goal is to see if specific markers in the blood can predict how well the treatment works. Participants will tak…